Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 5/20 | 0.35 |
| ▸ | DPP4 | P27487 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.32 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.32 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.32 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.32 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5203652 | 1.00 | GSR (0.42) | GSRTDP1TSHRMAPTCACNA1B | |
| SCHEMBL5203643 | 1.00 | GSR (0.42) | GSRTDP1TSHRMAPTCACNA1B | |
| SCHEMBL369325 | 0.95 | GSR (0.50) | GSRTDP1TSHRMAPTCACNA1B | |
| SCHEMBL369324 | 0.95 | GSR (0.50) | GSRTDP1TSHRMAPTCACNA1B | |
| SCHEMBL11667283 | 0.95 | GSR (0.50) | GSRTDP1TSHRMAPTCACNA1B | |
| Hydrochloric Acid SCHEMBL11554720 | 0.93 | GSR (0.48) | GSRTDP1TSHRMAPTCACNA1B | |
| Hydrochloric Acid SCHEMBL11554718 | 0.93 | GSR (0.48) | GSRTDP1TSHRMAPTCACNA1B | |
| SCHEMBL7950462 | 0.89 | TDP1 (0.39) | GSRTDP1TSHRMAPTCACNA1B | |
| SCHEMBL722132 | 0.87 | GSR (0.43) | GSRTDP1TSHRMAPTCACNA1B | |
| SCHEMBL30883910 | 0.84 | GSR (0.46) | GSRTSHRDDAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1297826-A1 | Nasal pharmaceutical compositions containing a NK-2 antagonist | Menarini Ricerche S.p.A. (IT) | 2003-04-02 | — | — | EP | claimed |
| WO-2023217589-A1 | POLYAMIDE MICROCAPSULES | FIRMENICH SA (CH) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023217590-A1 | POLYAMIDE MICROCAPSULES | FIRMENICH SA (CH) | 2023-11-16 | — | — | WO | disclosed |
| US-20140114048-A1 | Multi-Chromophoric Quencher Constructs for Use in High Sensitivity Energy Transfer Probes | APPLIED BIOSYSTEMS, LLC (US) | 2014-04-24 | — | — | US | disclosed |
| US-8586718-B2 | Multi-chromophoric quencher constructs for use in high sensitivity energy transfer probes | APPLIED BIOSYSTEMS, LLC (US) | 2013-11-19 | — | — | US | disclosed |
| WO-2010096853-A1 | METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR | MIMETICA PTY LTD (AU) | 2010-09-02 | — | — | WO | disclosed |
| EP-1789794-A1 | MULTI-CHROMOPHORIC QUENCHER CONSTRUCTS FOR USE IN HIGH SENSITIVITY ENERGY TRANSFER PROBES | Applera Corporation, Applied Biosystems Group (US) | 2007-05-30 | — | — | EP | disclosed |
| WO-2006031851-A1 | MULTI-CHROMOPHORIC QUENCHER CONSTRUCTS FOR USE IN HIGH SENSITIVITY ENERGY TRANSFER PROBES | APPLERA CORPORATION (US) | 2006-03-23 | — | — | WO | disclosed |
| US-20060063186-A1 | Multi-chromophoric quencher constructs for use in high sensitivity energy transfer probes | APPLERA CORPORATION (US) | 2006-03-23 | — | — | US | disclosed |
| EP-1297826-A1 | Nasal pharmaceutical compositions containing a NK-2 antagonist | Menarini Ricerche S.p.A. (IT) | 2003-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140114048-A1 | Multi-Chromophoric Quencher Constructs for Use in High Sensitivity Energy Transfer Probes | ABCG2, SLC46A1, QTRT1 | GSR 362/4885TDP1 140/4885TSHR 2683/4885 |
| US-20060063186-A1 | Multi-chromophoric quencher constructs for use in high sensitivity energy transfer probes | ABCG2, SLC46A1, QTRT1 | GSR 520/4885TDP1 328/4885TSHR 2570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.